Jodie Gawryluk

Dr. Jodie Gawryluk

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2014 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
JGJodie Gawryluk
Jodie Gawryluk
EMErin L. Mazerolle
Erin L. Mazerolle
RDRyan C.N. D'Arcy
Ryan C.N. D'Arcy
Functional magnetic resonance imaging (fMRI) is a non-invasive technique that allows for visualization of activated brain regions. Until recently, fMRI studies have focused on gray matter. There are two main reasons white matter fMRI remains controversial: 1) the blood oxygen level dependent (BOLD) fMRI signal depends on cerebral blood flow and volume, which are lower in white matter than gray matter and 2) fMRI signal has been associated with post-synaptic potentials (mainly localized in gray matter) as opposed to action potentials (the primary type of neural activity in white matter). Despite these observations, there is no direct evidence against measuring fMRI activation in white matter and reports of fMRI activation in white matter continue to increase. The questions underlying white matter fMRI activation are important. White matter fMRI activation has the potential to greatly expand the breadth of brain connectivity research, as well as improve the assessment and diagnosis of white matter and connectivity disorders. The current review provides an overview of the motivation to investigate white matter fMRI activation, as well as the published evidence of this phenomenon. We speculate on possible neurophysiologic bases of white matter fMRI signals, and discuss potential explanations for why reports of white matter fMRI activation are relatively scarce. We end with a discussion of future basic and clinical research directions in the study of white matter fMRI.

18 August 2017 in Frontiers in Human Neuroscience
Verified
Journal Article
Open access
VSVanessa Scarapicchia
Vanessa Scarapicchia
CBCassandra Brown
Cassandra Brown
CMChantel Mayo
Chantel Mayo
JGJodie Gawryluk
Jodie Gawryluk
Although blood oxygen level dependent (BOLD) functional magnetic resonance imaging (fMRI) is a widely available, non-invasive technique that offers excellent spatial resolution, it remains limited by practical constraints imposed by the scanner environment. More recently, functional near infrared spectroscopy (fNIRS) has emerged as an alternative hemodynamic-based approach that possesses a number of strengths where fMRI is limited, most notably in portability and higher tolerance for motion. To date, fNIRS has shown promise in its ability to shed light on the functioning of the human brain in populations and contexts previously inaccessible to fMRI. Notable contributions include infant neuroimaging studies and studies examining full-body behaviours, such as exercise. However, much like fMRI, fNIRS has technical constraints that have limited its application to clinical settings, including a lower spatial resolution and limited depth of recording. Thus, by combining fMRI and fNIRS in such a way that the two methods complement each other, a multimodal imaging approach may allow for more complex research paradigms than is feasible with either technique alone. In light of these issues, the purpose of the current review is to 1) provide an overview of fMRI and fNIRS and their associated strengths and limitations, 2) review existing combined fMRI-fNIRS recording studies, and 3) discuss how their combined use in future research practices may aid in advancing modern investigations of human brain function.

1 January 2017 in NeuroImage: Clinical
Verified
Journal Article
Open access
CMChantel D. Mayo
Chantel D. Mayo
EMErin L. Mazerolle
Erin L. Mazerolle
LRLesley Ritchie
Lesley Ritchie
JFJohn D. Fisk
John D. Fisk
JGJodie Gawryluk
Jodie Gawryluk
Alzheimer's disease (AD) is a progressive neurodegenerative disorder. Current avenues of AD research focus on pre-symptomatic biomarkers that will assist with early diagnosis of AD. The majority of magnetic resonance imaging (MRI) based biomarker research to date has focused on neuronal loss in grey matter and there is a paucity of research on white matter. Longitudinal DTI data from the Alzheimer's Disease Neuroimaging Initiative 2 database were used to examine 1) the within-group microstructural white matter changes in individuals with AD and healthy controls at baseline and year one; and 2) the between-group microstructural differences in individuals with AD and healthy controls at both time points. 1) Within-group: longitudinal Tract-Based Spatial Statistics revealed that individuals with AD and healthy controls both had widespread reduced fractional anisotropy (FA) and increased mean diffusivity (MD) with changes in the hippocampal cingulum exclusive to the AD group. 2) Between-group: relative to healthy controls, individuals with AD had lower FA and higher MD in the hippocampal cingulum, as well as the corpus callosum, internal and external capsule; corona radiata; posterior thalamic radiation; superior and inferior longitudinal fasciculus; fronto-occipital fasciculus; cingulate gyri; fornix; uncinate fasciculus; and tapetum. The current results indicate that sensitivity to white matter microstructure is a promising avenue for AD biomarker research. Additional longitudinal studies on both white and grey matter are warranted to further evaluate potential clinical utility.

9 January 2019 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
CMChantel D. Mayo
Chantel D. Mayo
MGMauricio A. Garcia-Barrera
Mauricio A. Garcia-Barrera
EMErin L. Mazerolle
Erin L. Mazerolle
LRLesley J. Ritchie
Lesley J. Ritchie
JFJohn D. Fisk
John D. Fisk
JGJodie Gawryluk
Jodie Gawryluk
Introduction: Alzheimer’s disease (AD) is a neurodegenerative disorder with a clinical presentation characterized by memory impairment and executive dysfunction. Our group previously demonstrated significant alterations in white matter microstructural metrics in AD compared to healthy older adults. We aimed to further investigate the relationship between white matter microstructure in AD and cognitive function, including memory and executive function. Methods: Diffusion tensor imaging (DTI) and neuropsychological data were downloaded from the AD Neuroimaging Initiative database for 49 individuals with AD and 48 matched healthy older adults. The relationship between whole-brain fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AxD), radial diffusivity (RD), and composite scores of memory and executive function was examined. We also considered voxel-wise relationships using Tract-Based Spatial Statistics. Results: As expected, individuals with AD had lower composite scores on tests of memory and executive function, as well as disrupted white matter integrity (low FA, high MD, AxD, and RD) relative to healthy older adults in widespread regions, including the hippocampus. When the AD and healthy older adult groups were combined, we found significant relationships between DTI metrics (FA/MD/AxD/RD) and memory scores across widespread regions of the brain, including the medial temporal regions. We also found significant relationships between DTI metrics (FA/MD/AxD/RD) and executive function in widespread regions, including the frontal areas in the combined group. However, when the groups were examined separately, no significant relationships were found between DTI metrics (FA/MD/AxD/RD) and memory performance for either group. Further, we did not find any significant relationships between DTI metrics (FA/MD/AxD/RD) and executive function in the AD group, but we did observe significant relationships between FA/RD, and executive function in healthy older adults. Conclusion: White matter integrity is disrupted in AD. In a mixed sample of AD and healthy elderly persons, associations between measures of white matter microstructure and memory and executive cognitive test performance were evident. However, no significant linear relationship between the degree of white matter disruption and level of cognitive functioning (memory and executive abilities) was found in those with AD. Future longitudinal studies of the relations between DTI metrics and cognitive function in AD are required to determine whether DTI has potential to measure progression of AD and/or treatment efficacy.

10 May 2016 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
CSColette M. Smart
Colette M. Smart
SSSidney J. Segalowitz
Sidney J. Segalowitz
BMBryce P. Mulligan
Bryce P. Mulligan
JKJacob Koudys
Jacob Koudys
JGJodie Gawryluk
Jodie Gawryluk
Introduction: Subjective cognitive decline (SCD) in older adults is a condition with a complex phenomenology and diverse etiologies including (but not limited to) mood, personality, and health concerns, as well as biomarkers of preclinical Alzheimer’

1 April 2010 in NeuroImage
Verified
Journal Article
Closed access
EMErin L. Mazerolle
Erin L. Mazerolle
SBSteven D. Beyea
Steven D. Beyea
JGJodie Gawryluk
Jodie Gawryluk
KBKimberly D. Brewer
Kimberly D. Brewer
CBChris V. Bowen
Chris V. Bowen
RDRyan C.N. D'ARcy
Ryan C.N. D'ARcy